Skip to content

Dash Knee

by Brainlab AG

510(k) K102251

Dash Knee is a medical device (FDA Class II; FDA product code OLO, Orthopedic Stereotaxic Instrument) made by Brainlab AG, cleared under FDA 510(k) K102251 on 17 May 2011, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK102251 Date17 May 2011ClearedStatusActive

Official records

From the FDA record

Received by the FDA
9 Aug 2010
FDA decision
17 May 2011 (Substantially Equivalent)
FDA review time
281 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K102251 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
OLO
Device class
Class II
Regulation
21 CFR Part 882.4560
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Devices cleared under K102251

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K102251
UDI-DISize and differences
Dash™ 18060B
Brainlab SE
18060B / 18060B04056481006815 —No longer on the market

Similar devices

Other devices filed under FDA product code OLO (Orthopedic Stereotaxic Instrument).

Other devices from Brainlab AG

  • Automatic Registration

    Class II
  • RT Elements (4.0)

    Class II
  • ENT Em

    Class II
  • Z-Touch

    Class II

See all devices from Brainlab AG →